Name | Number of supported studies | Average coverage | |
---|---|---|---|
naive thymus-derived CD4-positive, alpha-beta T cell | 7 studies | 23% ± 6% | |
regulatory T cell | 6 studies | 21% ± 5% | |
renal alpha-intercalated cell | 4 studies | 29% ± 8% | |
enterocyte | 3 studies | 22% ± 3% | |
retinal pigment epithelial cell | 3 studies | 30% ± 3% | |
epithelial cell | 3 studies | 21% ± 3% |
Insufficient scRNA-seq data for expression of ADTRP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 96% | 490.43 | 553 / 578 | 75% | 4.87 | 869 / 1155 |
stomach | 77% | 1118.87 | 275 / 359 | 77% | 8.53 | 219 / 286 |
kidney | 96% | 526.26 | 85 / 89 | 42% | 2.73 | 380 / 901 |
intestine | 57% | 1794.87 | 546 / 966 | 81% | 9.96 | 426 / 527 |
bladder | 48% | 143.57 | 10 / 21 | 66% | 5.39 | 334 / 504 |
skin | 84% | 897.43 | 1515 / 1809 | 29% | 0.96 | 136 / 472 |
lymph node | 0% | 0 | 0 / 0 | 93% | 9.43 | 27 / 29 |
tonsil | 0% | 0 | 0 / 0 | 89% | 7.63 | 40 / 45 |
esophagus | 9% | 13.63 | 123 / 1445 | 80% | 7.65 | 146 / 183 |
pancreas | 1% | 1.35 | 4 / 328 | 87% | 5.90 | 154 / 178 |
spleen | 78% | 164.73 | 189 / 241 | 0% | 0 | 0 / 0 |
thymus | 6% | 26.70 | 40 / 653 | 69% | 6.09 | 419 / 605 |
breast | 24% | 66.60 | 109 / 459 | 45% | 1.87 | 502 / 1118 |
uterus | 0% | 0 | 0 / 170 | 46% | 2.48 | 210 / 459 |
ovary | 0% | 0 | 0 / 180 | 44% | 1.69 | 191 / 430 |
peripheral blood | 43% | 117.35 | 399 / 929 | 0% | 0 | 0 / 0 |
prostate | 8% | 23.59 | 19 / 245 | 34% | 0.93 | 172 / 502 |
liver | 15% | 22.58 | 35 / 226 | 22% | 1.10 | 88 / 406 |
brain | 19% | 55.44 | 494 / 2642 | 8% | 0.28 | 58 / 705 |
eye | 0% | 0 | 0 / 0 | 14% | 0.31 | 11 / 80 |
adipose | 10% | 20.13 | 126 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 8.62 | 9 / 258 | 4% | 0.13 | 10 / 230 |
blood vessel | 7% | 13.93 | 96 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 1.66 | 8 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.26 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0003332 | Biological process | negative regulation of extracellular matrix constituent secretion |
GO_0030195 | Biological process | negative regulation of blood coagulation |
GO_0071383 | Biological process | cellular response to steroid hormone stimulus |
GO_1903038 | Biological process | negative regulation of leukocyte cell-cell adhesion |
GO_0042758 | Biological process | long-chain fatty acid catabolic process |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0002686 | Biological process | negative regulation of leukocyte migration |
GO_2000402 | Biological process | negative regulation of lymphocyte migration |
GO_0050709 | Biological process | negative regulation of protein secretion |
GO_0140052 | Biological process | cellular response to oxidised low-density lipoprotein particle stimulus |
GO_0009986 | Cellular component | cell surface |
GO_0012505 | Cellular component | endomembrane system |
GO_0005901 | Cellular component | caveola |
GO_0016020 | Cellular component | membrane |
GO_0016787 | Molecular function | hydrolase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ADTRP |
Protein name | Androgen dependent TFPI regulating protein Androgen-dependent TFPI-regulating protein (Fatty acid esters of hydroxy fatty acids hydrolase ADTRP) (FAHFA hydrolase ADTRP) (EC 3.1.-.-) |
Synonyms | C6orf105 |
Description | FUNCTION: Hydrolyzes bioactive fatty-acid esters of hydroxy-fatty acids (FAHFAs), but not other major classes of lipids . Show a preference for FAHFAs with branching distal from the carboxylate head group of the lipids . Regulates the expression and the cell-associated anticoagulant activity of the inhibitor TFPI in endothelial cells (in vitro) . . |
Accessions | ENST00000503285.1 ENST00000229583.9 [Q96IZ2-2] ENST00000414691.8 [Q96IZ2-1] ENST00000379415.6 H0Y9P4 ENST00000505099.5 ENST00000506810.1 H0YAA5 D6R9A9 Q96IZ2 D6RDG9 ENST00000485323.2 |